Cite
HARVARD Citation
Morita, A. et al. (2021). Long‐term analysis of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa: Open‐label phase 3 results. Journal of dermatology. 48 (1), pp. 3-13. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Morita, A. et al. (2021). Long‐term analysis of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa: Open‐label phase 3 results. Journal of dermatology. 48 (1), pp. 3-13. [Online].